C29H54N2O3, monoclinic, P21 (no. 4), a = 9.8091(11) Å, b = 7.6661(8) Å, c = 19.095(2) Å, β = 93.171(4)°, V = 1433.7(3) Å3, Z = 2, Rgt(F) = 0.0657, wRref(F2) = 0.1362, T = 250 K
C62H80Mn2N16O18, triclinic, P1̅ (no. 2), a = 11.3232(10) Å, b = 12.879(2) Å, c = 13.035(2) Å, α = 84...
In the title compound, C15H14IN3O2·CH3OH, two aromatic rings are linked by an N-substituted hydrazid...
C17H28N2O3, triclinic, P1 (no. 2), a = 6.098 Å, b = 11.703 Å, c = 12.721 Å, 2 = 81.95°, 0 = 80.11°, ...
C33H41N3O2, orthorhombic, P212121 (no. 19), a = 8.44861(4) Å, b = 17.00722(9) Å, c = 20.1555(1) Å, V...
C30H52O3, orthorhombic, P212121 (no. 19), a = 6.71147(14) Å, b = 16.6565(4) Å, c = 25.0815(6) Å, V =...
C32H52O5, monoclinic, P21 (no. 4), a = 11.816(2) Å, b = 7.4064(15) Å, c = 17.101(3) Å, β = 97.01(3)°...
C28H36FNO2, orthorhombic, P212121 (no. 19), a = 6.3277(3) Å, b = 11.9665(19) Å, c = 32.2419(19) Å, V...
C13H17NO3, monoclinic, P21/c, a = 7.7486(4) Å, b = 8.5148(3) Å, c = 19.9822(9) Å, β = 100.341(2)°...
C11H17NO2, monoclinic, P21/c (no. 14), a = 5.9245(2) Å, b = 17.7243(6) Å, c = 10.2915(4) Å, β = 9...
C20H15N3O·H2O, triclinic, P1̅ (No. 2), a = 7.066(3) Å, b = 9.996(4) Å, c = 12.873(5) Å, α = 86.007(1...
C18H20N6·2(CH3OH), triclinic, P1‾$P\overline{1}$ (no. 2), a = 5.0063(2) Å, b = 8.5627(5) Å, c = 12.8...
C18H27N5O6, monoclinic, P21/n (no. 14), a = 11.6588(12) Å, b = 7.0645(6) Å, c = 25.700(3) Å, β = 94....
C10H16N6O3, monoclinic, P21/c$P{2}_{1}/c$ (no. 14), a = 7.2312(1) Å, b = 17.7721(3) Å, c = 11.0146(2...
The title compound, C 35H 57 NO 3 0.25H 2O, was synthesized from deoxycholic acid followed by a pro...
C9H11NOS, monoclinic, P21/n (no. 14), a = 6.0194(4) Å, b = 20.9249(13) Å, c = 7.7103(5) Å, β = 107.7...
C62H80Mn2N16O18, triclinic, P1̅ (no. 2), a = 11.3232(10) Å, b = 12.879(2) Å, c = 13.035(2) Å, α = 84...
In the title compound, C15H14IN3O2·CH3OH, two aromatic rings are linked by an N-substituted hydrazid...
C17H28N2O3, triclinic, P1 (no. 2), a = 6.098 Å, b = 11.703 Å, c = 12.721 Å, 2 = 81.95°, 0 = 80.11°, ...
C33H41N3O2, orthorhombic, P212121 (no. 19), a = 8.44861(4) Å, b = 17.00722(9) Å, c = 20.1555(1) Å, V...
C30H52O3, orthorhombic, P212121 (no. 19), a = 6.71147(14) Å, b = 16.6565(4) Å, c = 25.0815(6) Å, V =...
C32H52O5, monoclinic, P21 (no. 4), a = 11.816(2) Å, b = 7.4064(15) Å, c = 17.101(3) Å, β = 97.01(3)°...
C28H36FNO2, orthorhombic, P212121 (no. 19), a = 6.3277(3) Å, b = 11.9665(19) Å, c = 32.2419(19) Å, V...
C13H17NO3, monoclinic, P21/c, a = 7.7486(4) Å, b = 8.5148(3) Å, c = 19.9822(9) Å, β = 100.341(2)°...
C11H17NO2, monoclinic, P21/c (no. 14), a = 5.9245(2) Å, b = 17.7243(6) Å, c = 10.2915(4) Å, β = 9...
C20H15N3O·H2O, triclinic, P1̅ (No. 2), a = 7.066(3) Å, b = 9.996(4) Å, c = 12.873(5) Å, α = 86.007(1...
C18H20N6·2(CH3OH), triclinic, P1‾$P\overline{1}$ (no. 2), a = 5.0063(2) Å, b = 8.5627(5) Å, c = 12.8...
C18H27N5O6, monoclinic, P21/n (no. 14), a = 11.6588(12) Å, b = 7.0645(6) Å, c = 25.700(3) Å, β = 94....
C10H16N6O3, monoclinic, P21/c$P{2}_{1}/c$ (no. 14), a = 7.2312(1) Å, b = 17.7721(3) Å, c = 11.0146(2...
The title compound, C 35H 57 NO 3 0.25H 2O, was synthesized from deoxycholic acid followed by a pro...
C9H11NOS, monoclinic, P21/n (no. 14), a = 6.0194(4) Å, b = 20.9249(13) Å, c = 7.7103(5) Å, β = 107.7...
C62H80Mn2N16O18, triclinic, P1̅ (no. 2), a = 11.3232(10) Å, b = 12.879(2) Å, c = 13.035(2) Å, α = 84...
In the title compound, C15H14IN3O2·CH3OH, two aromatic rings are linked by an N-substituted hydrazid...
C17H28N2O3, triclinic, P1 (no. 2), a = 6.098 Å, b = 11.703 Å, c = 12.721 Å, 2 = 81.95°, 0 = 80.11°, ...